WELCOME TO

Grann Pharmaceuticals

Advanced Nucleic Acid Therapeutics

Our Vision

At Grann Pharmaceuticals, innovation is our foundation. We are committed to advancing mRNA lipid nanoparticle research by delivering groundbreaking small molecule treatments at unprecedented speed. Our vision is to create a future where innovative therapies reach those in need faster, profoundly improving lives across the globe.

The Problem

Millions of people in the United States and globally are afflicted by diseases caused by single protein knockouts and mutations.

Solution

mRNA combined with lipid nanoparticle technology allows for the insertion of lost human proteins back into the human body intravenously.

Commitment to Rare Disease

Grann Pharmaceuticals is committed to advancing treatments for rare diseases by working closely with the communities affected. Our research focuses on conditions such as Rett syndrome and GABA-A variants, where we collaborate with leading experts, patients, and families to develop innovative therapies.

We believe that every rare disease deserves attention and every patient deserves hope. Our mission is to deliver transformative solutions to those who need them most.